Urinary Tract Infection Testing Devices Market Report 2025

This Urinary Tract Infection Testing Devices market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The urinary tract infection testing devices market size has grown strongly in recent years. It will grow from $0.62 billion in 2024 to $0.67 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth observed in the historical period can be linked to the rising disease burden, the increasing global incidence of urinary tract infections, the high prevalence of diabetes in low- and middle-income countries, the growing cases of hospital-acquired urinary tract infections, and the rising occurrence of antibiotic-resistant urinary tract infections.

The urinary tract infection testing devices market size is expected to see strong growth in the next few years. It will grow to $0.86 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. In the forecast period, growth is expected to be driven by the increasing availability of at-home and self-testing kits, a growing preference for early diagnosis, and the heightened urgency to address antibiotic resistance. Key trends in the forecast period include the integration of AI and machine learning, innovations in at-home testing, technological advancements, the use of nanotechnology-based diagnostics, and the development of CRISPR-based diagnostic tools.

The increasing prevalence of urinary tract infections (UTIs) is expected to drive the growth of the urinary tract infection testing devices market. UTIs can affect any part of the urinary system, such as the kidneys, ureters, bladder, or urethra, and are commonly caused by bacteria, with Escherichia coli being the most frequent pathogen. The rise in UTI cases is attributed to factors such as prolonged catheter use, poor hygiene practices, and growing antimicrobial resistance among hospitalized patients. UTI testing devices assist in the rapid and accurate diagnosis of UTIs, enabling healthcare providers to identify the causative bacteria and administer targeted treatments quickly. This helps reduce complications, improve patient outcomes, and limit the spread of antimicrobial resistance within healthcare environments. According to the University of New South Wales, a public research university in Australia, UTIs are widespread, with over 400 million cases reported globally each year. As a result, the rising incidence of UTIs is fueling the demand for urinary tract infection testing devices.

Leading companies in the UTI testing devices market are focusing on developing point-of-care (POC) testing devices that offer quicker, more convenient diagnoses, improving patient care. POC testing allows medical diagnostics to be performed at or near the patient's location, such as at a doctor's office, hospital bedside, or even at home, without the need for laboratory sample processing. For example, in June 2023, Sysmex Corporation, a Japanese company, introduced the PA-100 AST System, a point-of-care testing system for detecting antimicrobial susceptibility. This system can identify bacterial presence in urine and assess the effectiveness of antimicrobials in under 30 minutes. It provides results on bacterial growth in about 10 minutes and offers susceptibility test outcomes in less than 30 minutes, enabling healthcare professionals to conduct rapid tests on patients suspected of having UTIs.

In September 2022, Advanced MedTech, a Singapore-based medical device manufacturer, acquired a majority stake in Shenzhen Wikkon Medical Apparatus Co. Ltd., a Chinese company specializing in UTI testing devices. This acquisition, made for an undisclosed amount, was intended to expand Advanced MedTech’s product portfolio and strengthen its market position by leveraging Wikkon's expertise in diagnostic equipment, enhancing its technological capabilities and competitive advantage in the healthcare industry.

Major players in the urinary tract infection testing devices market are Cardinal Health Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Siemens Healthcare GmbH, Stryker Corporation, Laboratory Corporation of America Holdings, Biomerieux Pvt. Ltd., Coloplast A/S, Sysmex Corporation, Quidel Corporation, Teleflex Incorporated, Teleflex Incorporated, Bio-Rad Laboratories, QIAGEN NV, ACON Laboratories Inc., Randox Laboratories Ltd., ARKRAY Inc., T2 Biosystems Inc.

North America was the largest region in the urinary tract infection testing devices market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in urinary tract infection (UTI) testing devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the urinary tract infection (UTI) testing devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Urinary tract infection (UTI) testing devices are medical instruments designed to diagnose infections in the urinary system by identifying bacteria, white blood cells, or other indicators in urine samples. These devices vary from simple dipsticks and culture kits to more sophisticated automated analyzers, offering fast and precise results that help guide treatment decisions.

The primary types of UTI testing devices include instruments and kits. UTI testing kits are popular for their convenience and affordability, making them commonly used in point-of-care environments and for self-testing. The different types of tests include urinalysis, urine cultures, and susceptibility testing, and they are utilized by various end-users such as hospitals, diagnostic laboratories, and other healthcare providers.

The urinary tract infection testing devices market research report is one of a series of new reports that provides urinary tract infection testing devices market statistics, including urinary tract infection testing devices industry global market size, regional shares, competitors with a urinary tract infection testing devices market share, detailed urinary tract infection testing devices market segments, market trends and opportunities, and any further data you may need to thrive in the urinary tract infection testing devices industry. This urinary tract infection testing devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The urinary tract infection (UTI) testing devices market consists of sales of urine analyzers, dipsticks, and culture systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.